The results indicate that patients in the BCS group had better PO clinical parameters(increase in IPO and HD Hb and IPO and HD Ht) and outcomes (decrease of PO RBC,length of stay, and infection rates) compared to patients in the WBCS group aftercardiac surgery with CPB. The gene discussed is GSTM1; the disease is infection.